Correlation Between Brainstorm Cell and Schibsted ASA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Brainstorm Cell and Schibsted ASA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Brainstorm Cell and Schibsted ASA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Brainstorm Cell Therapeutics and Schibsted ASA A, you can compare the effects of market volatilities on Brainstorm Cell and Schibsted ASA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Brainstorm Cell with a short position of Schibsted ASA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Brainstorm Cell and Schibsted ASA.

Diversification Opportunities for Brainstorm Cell and Schibsted ASA

-0.77
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Brainstorm and Schibsted is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Brainstorm Cell Therapeutics and Schibsted ASA A in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Schibsted ASA A and Brainstorm Cell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Brainstorm Cell Therapeutics are associated (or correlated) with Schibsted ASA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Schibsted ASA A has no effect on the direction of Brainstorm Cell i.e., Brainstorm Cell and Schibsted ASA go up and down completely randomly.

Pair Corralation between Brainstorm Cell and Schibsted ASA

Assuming the 90 days trading horizon Brainstorm Cell Therapeutics is expected to under-perform the Schibsted ASA. In addition to that, Brainstorm Cell is 2.89 times more volatile than Schibsted ASA A. It trades about 0.0 of its total potential returns per unit of risk. Schibsted ASA A is currently generating about 0.09 per unit of volatility. If you would invest  1,018  in Schibsted ASA A on September 3, 2024 and sell it today you would earn a total of  2,136  from holding Schibsted ASA A or generate 209.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.8%
ValuesDaily Returns

Brainstorm Cell Therapeutics  vs.  Schibsted ASA A

 Performance 
       Timeline  
Brainstorm Cell Ther 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Brainstorm Cell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Schibsted ASA A 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Schibsted ASA A are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Schibsted ASA reported solid returns over the last few months and may actually be approaching a breakup point.

Brainstorm Cell and Schibsted ASA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Brainstorm Cell and Schibsted ASA

The main advantage of trading using opposite Brainstorm Cell and Schibsted ASA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Brainstorm Cell position performs unexpectedly, Schibsted ASA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Schibsted ASA will offset losses from the drop in Schibsted ASA's long position.
The idea behind Brainstorm Cell Therapeutics and Schibsted ASA A pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.